Saman Adnan: New Research Explores Readmission Risk in Brain Cancer Patients With VTE
Saman Adnan, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood, adding:
“Thrilled to share that our team’s abstract has been published in the journal ‘Blood‘ as part of the ‘67th ASH Annual Meeting Abstracts‘!
As the group leader of this incredible, multi-institutional research group, it has been an absolute privilege to work with my fellow talented co-authors and mentor, Jawad Ahmed.
Working alongside such talented peers from across different institutions has been an incredibly rewarding experience.
Our study, ‘Thirty-day readmission in patients with brain cancer and venous thromboembolism: A nationwide analysis using the national readmissions database,’ looks closely at a highly vulnerable neuro-oncologic population.
Venous thromboembolism (VTE) is a severe, life-threatening complication for brain cancer patients, yet data on what drives early hospital readmissions has been limited.”
Title: Thirty-day readmission in patients with brain cancer and venous thromboembolism: A nationwide analysis using the national readmissions database
Authors: Jawad Ahmed, Muhammad Umer Sohail, Muhammad Asjad Riaz, Jazza Jamil, Ahmad Khan, Saman Adnan, Muskan Kumari, Muhammad Umair Noor, Zain Ali Nadeem, Jay Kakadiya, Fnu Bhuvan
Stay updated on all scientific advances with Hemostasis Today.
-
May 30, 2026, 10:27Sartaj Alam: CBC Analyzer – The Backbone of Modern Hematology Diagnostics
-
May 30, 2026, 10:17Factor X Deficiency – From Mild Bruising to Life Threatening Hemorrhage – ICHCC
-
May 30, 2026, 10:06Johann Morelle: Complement Inhibitors Are Reshaping Modern Nephrology
-
May 30, 2026, 09:49Flora Peyvandi: Exploring a Multidisciplinary Care Model for Hemophilia and Rare Diseases
-
May 30, 2026, 08:59Li-Chia Chen: Advancing Patient Care Through Pharmacist Innovation at KUTRRH
-
May 30, 2026, 08:58Ben Creagh-Brown: How Should HI-PEITHO Influence the Management of Intermediate-Risk Pulmonary Embolism?
-
May 30, 2026, 08:56Reidiel Suárez Borges: Understanding the INR in Anticoagulation Management
-
May 29, 2026, 17:23Rita Schwab: Current Clinical Management of Trauma without the Use of Allogenic Blood Products
-
May 29, 2026, 17:22Brian Schiro: Excited to Provide Guideline Based Care at the Aortic Center